Clinical Trials Logo
  1. Home
  2. Refractory Ascites
  3. NCT00870662

A Feasibility Study of the Automated Fluid Shunt (AFS) for Automated Ascites Removal

Refractory Ascites Clinical Trial

Official title:
A Feasibility Study of the Automated Fluid Shunt (AFS) for Automated Ascites Removal

Clinical Trial Summary

The purpose of this study is to determine whether the Automatic Fluid Shunt (AFS) can reduce the number of paracentesis procedures in patients with refractory ascites.

Clinical Trial Description

n/a

Study Design

Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT00870662
Study type Interventional
Source NovaShunt AG
Contact
Status Completed
Phase N/A
Start date December 2008
View Details
See also
  Status Clinical Trial Phase
Active, not recruiting NCT04050683 - Evaluation of Hemodynamic Parameters Following Transjugular Intrahepatic Portosystemic Shunt (TIPS) N/A
Active, not recruiting NCT01438970 - Effects of Treatment of Ascites by the ALFApump System on Renal and Circulatory Function Phase 2
Completed NCT00240045 - The Use of Drugs to Improve Kidney Function in Patients With Liver and Kidney Dysfunction Phase 2/Phase 3
Not yet recruiting NCT04621617 - Midodrine and Albumin in Patients With Refractory Ascites Phase 3
Recruiting NCT05700708 - Point-of-Care Echocardiography to Assess Impact of Dynamic Cardiac Function, Renal and Cardiac Biomarkers in Cirrhosis With Refractory Ascites
Terminated NCT02026609 - Glutamine Challenge as Predictor of Hepatic Encephalopathy After Transjugular Intrahepatic Portosystemic Shunt (TIPS) N/A
Recruiting NCT01558895 - Infrared Ray Heat Treatment in Liver Cirrhosis Patients With Refractory Ascites Phase 2/Phase 3
Recruiting NCT04043858 - Safety and Efficacy of Midodrine Hydrochloride in the Management of Refractory Ascites Due to Cirrhosis in Children N/A
Completed NCT01532427 - ALFApump System Post Marketing Surveillance Registry
Completed NCT01440829 - The Effectiveness of L-ornithine-L-aspartate (LOLA) on Plasma Ammonia in Cirrhotic Patients After TIPS Phase 2/Phase 3
Active, not recruiting NCT05434286 - Point-of-Care Echocardiography to Assess Impact of Dynamic Cardiac Function, Renal and Cardiac Biomarkers in Cirrhosis With Hepatorenal Syndrome-Acute Kidney Injury
Completed NCT06196723 - Early Transjugular Intrahepatic Portosystemic Shunts Improve Survival in Patients With Cirrhosis and Recurrent Ascites